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Abstract
Epithelia and endothelia delineate tissue compartments and control their environments by regulating the passage
of ions and solutes. This barrier function is essential for the development and maintenance of multicellular
organisms, and its dysfunction is associated with numerous human diseases. Recent advances in biomaterials and
microfabrication technologies have evolved in vitro approaches for modelling biological barriers. Current
microphysiological systems have become more efficient and reliable in mimicking the cell microenvironment.
Additionally, methods for the quantification of barrier permeability have long provided significant insight into their
underlying mechanisms. In this review, we outline the current techniques to quantify the barrier function of
engineered tissues, and we also give an overview of recent microphysiological systems of biological barriers that
emulate the microenvironment and microarchitecture of native tissues.
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Background
Physical barriers to separate different compartments are
essential for the development and maintenance of multi-
cellular organisms and are integral to numerous organs.
Epithelia and endothelia form these vital barriers. They
delineate tissue compartments and control their environ-
ments by regulating the passage of ions and solutes [1].
Some examples are renal tubule epithelium and blood ca-
pillaries. The physiological function of these biological
barriers is diverse among tissues and responds to the par-
ticular needs of each organ, including the supply of nutri-
ents, the absorption of ions, the secretion of waste, the
protection against toxins, and the filtration of fluids. The
deregulation of their essential function can lead to serious
health complications. Numerous endothelia and epithelia
dysfunctions are associated with prevalent human diseases
such as hereditary diseases (e.g., hypomagnesemia),
gastrointestinal tract diseases (e.g., Crohn’s disease), or
viral infections (e.g., hepatitis C) [2–4].
Recent advances in microtechnologies and biomate-
rials have provided a new set of tools to construct rele-
vant microphysiological systems (MPS) [5, 6]. These
engineered devices aim to recapitulate tissues- and
organ-level functions and are promising constructs for
disease modelling and drug development applications.
Although cell cultures may not capture all of the complex-
ity of the in vivo system, the barrier models being devel-
oped are enhancing our ability to more closely mimic the
in vivo environment and therefore better predict cell be-
haviour in vivo. To date, this technology has led to the en-
gineering of diverse systems for modelling human diseases
[7] and also for mimicking biological barriers of the lung
[8], kidney [9], and brain [10], among others. Since the
major function of a cell barrier is to regulate and to separ-
ate two distinct physiological compartments, the strategy
to build more relevant in vitro models usually lies in
compartmentalization of different environments [11].
Most engineered cell barrier approaches utilize physical
interfaces for such propose and to support cells (e.g., per-
meable membranes or gel-liquid interfaces).
Besides compartmentalization, quantifying the perme-
ability of barrier tissues is necessary to assess the state of
the barriers and identify the factors contributing to barrier
dysfunction. For example, in toxicology, the monitoring of
the barrier integrity permits to evaluate the effects of toxic
compounds; in disease modelling, to examine a barrier
breakdown during a disease progression; or in drug devel-
opment, to test the ability of new drugs to cross the
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barriers. In addition to tracer assays and immunocyto-
chemistry, transepithelial electrical measurements—per-
formed with extracellular electrodes in apical and basal
sides—have been an essential methodology to quantify ion
permeability and to elucidate important epithelial proper-
ties. These electrical measurements are non-invasive and
yield information about the voltage, resistance, and
current across the epithelium. Measuring these parame-
ters under special conditions, it is possible to determine
ion transepithelial transports and the electromotive forces
generated by active transporters. Transepithelial electrical
properties have also been widely used to determine ion se-
lectivity, ion permeability, and electrophysiological
characterization of epithelial tissues [12–14].
In this review, after introducing how epithelial and
endothelial cells form functional barriers and describing
some vital biological barriers of the human body, we
outline the current techniques to quantify the barrier
function of engineered tissues, focusing on permeability
assays and transepithelial electrical measurements. Then,
we give and overview of recent MPS for modelling bio-
logical barriers that emulate the cell microenvironment
and microarchitecture of native tissues. Finally, we dis-
cuss the future perspectives in engineering and monitor-
ing epithelial and endothelial barrier models.
Epithelial and endothelial tissues
Epithelial and endothelial sheets are formed by cells that
are attached together sealing the intercellular space and
thus providing a physical barrier. This tissue configuration
leads to two possible routes for solutes to cross the bar-
rier: 1) the transcellular pathway in which ions and mole-
cules pass through the cell membrane and 2) the
paracellular pathway where solutes cross between cells
(Fig. 1a). Ion and molecule movement along the paracellu-
lar route is passive and requires a driving force such as a
concentration gradient, an electrical potential difference, a
hydrostatic pressure, or an osmotic gradient. The combin-
ation of both chemical gradient and electric voltage leads
to an electrochemical gradient which accounts for most of
the ion passive transport. Moreover, to move substances
against their electrochemical gradient, cells have an active
transcellular mechanism of transport (i.e., active transport)
involving transmembrane proteins. This active transport
coexists with the passive one in the transcellular route.
The permeability of cellular barriers is very dynamic
and responds to extracellular stimuli and mediators by a
cascade of signalling mechanisms [15] involving a
cross-talk between paracellular and transcellular path-
ways [16]. For example, the kidney finely controls the
whole body balance of calcium, phosphate, and
Fig. 1 Transepithelial transport routes and intercellular junctions. a Paracellular and transcellular pathways across an epithelial layer. b, c Structure
and localization of TJ strands including (b) freeze-fracture replica electron microscopic image (scale bar, 200 nm) and (c) ultrathin sectional view
(scale bar, 50 nm). Mv, microvilli; Ap, apical membrane; Bl, basolateral membrane. Adapted by permission from Macmillan Publishers Ltd.: Nature
Reviews Molecular Cell Biology [1], copyright 2001. d Schematic representation of the intercellular space and the junctional protein complex
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magnesium by regulating the reabsorption of these ions
in the renal tubule [17]. Another signalling cascade is
initiated in blood vessels resulting in increased perme-
ability when they are subjected to inflammatory stimuli,
such as thrombin or tumour necrosis factor alpha
(TNF-α) [18].
Barrier function
The proper functioning of a barrier tissue depends on the
polarization of cells by different membrane lipids and pro-
tein on their apical and basolateral sides [19]. The close
contact between cells makes possible this apicobasal
membrane polarity preventing the intermixing of special-
ized apical and basal membrane composition. Each cell
type has its particular junctional complex with a mixture
of different types of cell-cell junctions (Fig. 1b–d). There
are basically four types of well-differentiated intercellular
junctions between adjacent cells: 1) gap junctions chan-
nels link the cytoplasm of two cells and serve to exchange
ions and small molecules, 2) desmosomes and 3) adherens
junctions contribute to physically anchor the cells to-
gether, and 4) tight junctions (TJ) bring closer apposed
membranes, being primarily responsible for controlling
the passive transport of solutes through the paracellular
pathway [20, 21].
TJ comprise a complex protein network [22], including
transmembrane proteins found within plasma mem-
brane as a branching network of strands. Each strand in
turn is associated with another strand from the apposed
membrane creating close contact points, the so-called
‘kissing points’, in which the intercellular space is obliter-
ated (Fig. 1c). The number of strands is variable and dif-
fers among cell types. Claude et al. observed that the
junctional tightness was logarithmically related to the
number of strands instead of proportionally related,
which led him to propose the existence of permeable
pores that dynamically and randomly open and close for
short periods of time [23]. New high-resolution ap-
proaches to detect flux across individual transmembrane
protein channel suggest the possible existence of the dy-
namic behaviour, proposed many years ago by Claude et
al., in the sub-millisecond timescale [24, 25]. Thus, TJ
could finely regulate the barrier permeability by this dy-
namic gating in addition to the more well-known modu-
lation by protein remodelling. In addition to the barrier
function, TJ also act as a fence that restricts the diffusion
of protein complexes and lipids within the plasma mem-
brane. Thus, the TJ define the interface between apical
and basal domains.
The understanding of TJ has vastly increased in the re-
cent years and particular junctional proteins have been
linked to specific barrier functions. However, the underlying
mechanisms regulating such functions remain to be deter-
mined [3]. It is now clear that TJ not only physically seal
the intercellular space but also form permeable channels
that have charge and size selectivity [26, 27]. This selectivity
supports the wide variety of permeability properties among
epithelial and endothelial tissues, which is critical to main-
tain and regulate the fluid composition between distinct
compartments in the organs. Therefore, their deregulation
involves functional disorders in vital organs.
In the brain, diverse neurological diseases—stroke, epi-
lepsy, Alzheimer’s disease, and multiple sclerosis, among
others—share common blood-brain barrier (BBB) disrup-
tion that contributes to the severity of such diseases [28].
The BBB is formed by brain capillaries that separates the
blood from the central nervous system (CNS) [29, 30]. In
the retina, alterations of the blood-retinal barrier (BRB)
[31]—which is similar to the BBB but protecting the ner-
vous tissue of the retina—are directly associated with two
leading cause of blindness in developed countries: diabetic
retinopathy and age-related macular degeneration. Brain
capillary endothelium is among the tighter endothelia in
the human body, in which well-developed TJ severely re-
strict the passage of solutes. Unlike continuous capillaries
such as the ones in the BBB and BRB, sinusoids are dis-
continuous and fenestrated (i.e., cell perforated) capillaries
with high permeability, which facilitate the diffusion of
solutes. The unique liver sinusoidal endothelial cell
(LSEC) phenotype—including fenestration and lack of a
basement membrane—is vital in maintaining functional
hepatocytes. Dysregulation of the LSEC phenotype is an
early stage of liver fibrosis that can progress to cirrhosis
and liver failure [32].
Systemic inflammation can disrupt biological barriers; for
instance, a persistent inflammatory state in the gut can
compromise brain barriers and contribute to neurodegener-
ative disorders via the gut-brain axis [33, 34], which permits
the dialogue between the gastrointestinal system and the
CNS. Intestinal microbiota regulates CNS activity [35] and
can promote these inflammatory conditions that in turn
impair the intestinal barrier (i.e., epithelium and mucosa)
and contributes to pathogenesis of inflammatory bowel dis-
eases, such as Crohn’s disease and ulcerative colitis [36]. In
the kidney, tubular epithelial cells that form the renal tu-
bule may play a key role in driving interstitial inflammation
and fibrosis that progress to chronic kidney disease (CKD)
[37]; after an acute kidney injury, renal epithelium damage
may be an early stage of renal failure. Furthermore, acute
lung injury can damage the integrity of the
alveolar-capillary barrier (which separates air from blood at
the alveoli in the lung) resulting in a fluid leakage from ca-
pillaries to alveolar spaces and a subsequent pulmonary
oedema with a potential risk of respiratory failure [38].
Cell microenvironment
Many microenvironment factors critically influence epi-
thelial and endothelial tissues (Fig. 2). For example, most
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epithelia produce an extracellular matrix (ECM) that
support them and interface with other tissues acting as a
diffusion barrier for the exchange of molecules. More-
over, cells react to physical and biochemical stimuli in
the surrounding environment, which allows them to
interact with other cell types and to dynamically adapt
their barrier function to particular physiological needs.
Extracellular matrix (ECM)
The ECM is a three-dimensional (3D) structure funda-
mentally composed of water, proteins, and polysaccha-
rides that physically supports cells within the organs
[39]. Components of the ECM are produced by cells and
secreted into the extracellular space where they are as-
sembled into diverse structures, primarily collagen fibres.
There are two general organizations of ECM depending
on their localization and composition: 1) the basement
membrane, which is a sheet-like layer mostly composed
of collagen IV and laminins that separates epithelia from
connective tissue; and 2) the interstitial matrix, which
surrounds cells forming a porous scaffold for tissues and
mainly consists of collagen I and fibronectin. The ECM
regulates many essential cellular functions such as prolif-
eration, migration, differentiation, and cell fate [40, 41].
Rather than being a rigid and static matrix complex, the
ECM is constantly interacting with surrounding cells
and remodelling itself to maintain tissue homeostasis.
Cell-ECM interaction is mediated via biochemical signals
coming from membrane receptor proteins (e.g., integ-
rins) that link the matrix to the cytoskeleton and activate
intracellular signalling pathways. Thus, ECM dictates
important cellular behaviours. For example, Cell-ECM
adhesion by specific membrane receptors marks an
asymmetry of the cell surface that is involved in the es-
tablishment of cell polarity [42].
Cell-cell communication
Cell to cell interaction through messaging signals is fun-
damental to cooperate and thus succeed in the mainten-
ance of tissue homeostasis. This communication is
typically established using signalling biomolecules and
can be divided into four categories: 1) direct contact in
which cells share some binding molecules or in which
small molecules diffuse between apposed cells via gap
junctions, 2) autocrine signalling where a molecular
messenger is released and subsequently bound to the
same cell, 3) paracrine signalling where the signal
reaches a nearby cell, and 4) endocrine signalling in
which hormones travel long distances through the
bloodstream and reach distant target cells. Heterotypic
cell-cell interaction is necessary to maintain the barrier
function of most epithelial and endothelial tissues. For
Fig. 2 Physical and biochemical cues in the cell microenvironment. Schematic drawing of an epithelial tubule and an endothelial capillary
embedded within an ECM. It includes cell-cell communications (i.e., direct contact, autocrine, and paracrine communications), flow-induced shear
stress, ECM involving basement membrane and interstitial matrix components, and cell-ECM interaction through membrane receptor proteins
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example, although the BBB is physically created at the
vascular endothelium, surrounding cells (e.g., pericytes,
astrocytes, and neurons) play an important role in the
barrier regulation [43]. Pericytes are essential during
BBB development [44], and their lack or the disruption
of their interaction with endothelial cells disrupt the
BBB integrity [45, 46].
Biochemical cues
Some soluble factors such as hormones, cytokines, and
growth factors serve as extracellular molecules for cell
signalling and regulate fundamental cellular processes in
barrier tissues. For example, growth factors stimulate
cell growth, cell proliferation, and cell differentiation. In
addition, a multitude of cytokines modulate epithelial
barrier functions. In the gut, mucosal inflammation in-
creases epithelial permeability via TJ disassembly, in part
because activated immune cells release certain inflam-
matory cytokines [47, 48]. Indeed, specific cytokine in-
hibitors restore homeostasis in intestinal inflammation.
Similar increased permeability were demonstrated in
other epithelia such as airway epithelium when these are
exposed to certain cytokines such as TNF-α and inter-
feron gamma (IFN-γ) [49]. In the BBB, interleukins
(IL-1α, IL-1β, and IL-6) and TNF-α cause the disruption
of the barrier increasing the ion permeability of the BBB
[50, 51]. In contrast, other chemical agents like some
hormones (e.g., adrenomedullin and hydrocortisone)
have the opposite effect on the BBB by tightening and
strengthening the barrier [52, 53].
Physical cues
Cells are also able to sense the external physical environ-
ment such as the topography and the stiffness of the
ECM. These physical features are transduced into a bio-
chemical response through integrin-based adhesions
complexes in a process known as mechanotransduction
[54]. In particular, matrix stiffness regulates proliferation,
migration, and cell-cell adhesion, among others, and its
stiffening can lead to the progression of tumour angio-
genesis [55], while the topography of the underlying
ECM influences cell morphology and cell differentiation,
among others [56].
Other physical forces, like the hemodynamic shear
stress and intercellular forces through adherent junc-
tions, coexist in the cell microenvironment and critically
influence cell function and cell behaviour. Endothelial
cells lining blood vessels sense hemodynamic shear
stress acting on vessel walls. A sustained physiological
variation of the shear stress has been found to stimulate
vascular remodelling and to increase nitric oxide pro-
duction by endothelial cells [57, 58]. In addition, many
in vitro and in vivo studies have reported a
shear-dependent endothelial permeability [59]. As in
blood vasculature, shear stress is also a relevant physio-
logical stimulus for epithelial tissues. For example, renal
tubular epithelial cells are exposed to a shear stress on
account of the filtrate flowing across the tubular lumen
and are able to transduce this mechanical force at
microvilli and primary cilia processes.
Barrier function quantification
The ability to quantify the transepithelial transport in a
barrier model is essential. Most common laboratory
techniques are based on permeability assays and transe-
pithelial electrical measurements. The former can be
used to determine apparent permeability coefficients of
test compounds (e.g., to predict drug absorption),
whereas the later provides information on transepithelial
ion transport (e.g., to assess barrier integrity). Since TJ
have charge and size selectivity, the permeability quanti-
fication of charged and uncharged species often gives
complementary information [60].
Permeability assays
Permeability assays consist in tracer diffusion measure-
ments in which the tracers are added in a donor com-
partment (i.e., the apical or basolateral side) and
quantified in a received compartment (i.e., the opposite
side) along time. Tracers can be monitored using a
fluorescent dye (e.g., fluorescein isothiocyanate [FITC]
and Rhodamine) or a radiolabelled marker (e.g., [14C]
mannitol). In a single capillary, the apparent permeabil-
ity coefficient (in cm s− 1) can be calculated considering
a lineal relation between fluorescent intensity and the
amount of the compound as
Papp ¼ 1ΔI f
dI f
dt
 
0
r
2
ð1Þ
where If is the fluorescent intensity in an optical window
containing the capillary, ΔIf is the fluorescence intensity
increase after perfusing the lumen with a fluorescent la-
belled tracer, (dIf/dt)0 is the initial rate of increase in
fluorescent intensity, and r is the capillary radius in cm
[61]. Alternatively, in cell cultures, the Papp for a com-
pound is calculated as
Papp ¼ dQdt
1
AC0
ð2Þ
where dQ/dt is the steady-state flux in μmol s− 1, A is
the cell culture area in cm− 1, and C0 is the initial con-
centration in the donor compartment in μmol. This
methodology permits to assess the transepithelial trans-
port in both directions, distinguishing between active
and passive transport mechanisms. For example, if the
Papp calculated in the apical to basolateral direction is
Yeste et al. Journal of Biological Engineering  (2018) 12:18 Page 5 of 19
higher than in the opposite direction, it involves an ac-
tive uptake of such compound. Additionally, specific
transporter inhibitors can elucidate their transport con-
tributions. To ensure the barrier integrity during perme-
ation assays, especially at the end of the experiments,
these studies are usually combined with transepithelial
electrical measurements or also with transport studies
using hydrophilic paracellular markers (e.g., mannitol
and dextran). Detailed information on the protocol of
permeability assays can be found in ref. [62].
Most common applications of permeability assays aim
to predict drug permeability across cellular barriers. In
the pharmaceutical industry, permeability assays using
Caco-2 monolayers are the gold standard to predict in-
testinal absorption and thus to estimate human drug
oral absorption [63]. In addition, assays using tracers
with different molecular weights were crucial to reveal
the size-selectivity of the TJ and to estimate their poros-
ity and pore size [64, 65].
Transepithelial electrical measurements
Transepithelial electrical measurements permits to
quantify ion permeability and barrier function in cell
cultures. Its major advantages are the non-invasiveness
and the real timing of the measurement. On the con-
trary, tracer assays may be more sensitive, especially in
leakier cell monolayers, but require long time periods
for tracers to diffuse and need labelling. As a disadvan-
tage, these measurements are difficult to interpret be-
cause they are the result of a combination of many
cellular electrical parameters. For this reason, some as-
sumptions and simplifications are usually considered to
interpret the results. This technique is based on the
measurement of the electrical properties of the cellular
sheet by means of extracellular electrodes. In particular,
a voltage or current perturbation is applied between
electrodes placed in both sides of the barrier. The mea-
surements that give primary information about a cellular
barrier are transepithelial voltage (Vte), transepithelial
electrical resistance (TEER), and short-circuit current
(Isc). These parameters are related by Ohms law as
TEER ¼ ΔV te
ΔI
ð3Þ
where ΔVte is the change in Vte and ΔI is the change in
the current flowed.
Transepithelial voltage
In epithelial tissues, the transepithelial ion transport is
driven by active transporters, chemical gradients, and
electrical forces due to potential differences. The net
movement of ions across epithelia may lead to a charge
imbalance between apical and basolateral sides that gen-
erates a transepithelial potential difference; this will be
the sum of both apical and basolateral membrane poten-
tial differences.
Transepithelial electrical resistance
TEER is the paracellular sum of two ion conductive
pathways, the paracellular resistance and the transcellu-
lar resistance. This parameter allows to monitor the cell
barrier integrity during experiments and to electrically
characterize barrier tissues. Epithelia and endothelia are
traditionally grouped in two classes according to their
transepithelial resistances: 1) ‘leaky’ epithelia when they
have low TEER values and lower paracellular resistance
compared to the transcellular one, and 2) ‘tight’ epithelia
in which the TEER is much higher and the paracellular
and transcellular resistances are similar. The BBB is an
example of tight barrier with high selectivity and low
permeability, which allows to protect the brain from po-
tentially harmful substances (e.g., bacterial toxins and in-
fectious agents); in situ measurement of TEER is
reported to be 1462 Ω cm2 in rats [66] and 1850 Ω cm2
in frogs [67]. In the kidney, the distal nephron also pre-
sents a tight barrier in order to preserve the diluted fil-
trate coming from previous tubular segments (850 Ω
cm2 in the distal tubule and 1000 Ω cm2 in the collect-
ing duct [68]). Otherwise, the proximal tubule of the
nephron is a leaky barrier that permits rapid paracellular
transport of ions and water molecules from the lumen
to the interstitial space (6–10 Ω cm2 [68]).
Short-circuit current
Under particular experimental conditions in which there
is no electrochemical gradient across the epithelium (i.e.,
apical and basal solutions are the same, and Vte is
clamped to zero), active ion transport generates a meas-
urable electrical current, the so-called ‘short-circuit
current’ (Isc). Although this current represents the net
transport of all ions species, Isc variations when remov-
ing such ion from the solution could estimate the active
transport of one ion species.
Equivalent electric circuit and impedance analysis
The transepithelial impedance across a cellular mono-
layer can be described in terms of an electric circuit con-
taining resistances and capacitances: 1) two capacitances
(Ca and Cb) that represent the apical and the basolateral
cell membranes, 2) two resistances (Ra and Rb) that de-
scribe the ion permeability of the cell membranes, and
3) a paracellular resistance (Rp) to represent the selective
ion route through the TJ (Fig. 3a). An additional resist-
ance (Rs) is often added in the circuit to describe the so-
lution resistance between the electrodes and the cell
layer. This five-variable model has to be solved with
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additional measurements; however, it is possible to ob-
tain a two-variable model by lumping the elements. In a
first step, the contributions from apical and basolateral
membranes are grouped in a single transcellular resist-
ance (Rt) and a cell layer capacitance (Ccl) (Fig. 3b). This
can be done if RaCa and RbCb are similar. In a second
step, the transcellular and the paracellular resistances
are grouped in the TEER (Fig. 3c). Representative im-
pedance spectra obtained across a cell layer are
shown in Fig. 3d and e for the frequency range of
interest (~ 10 Hz–1 MHz). An advantage of imped-
ance spectroscopy is the discrimination between Rs
and TEER unlike measurements systems using a sin-
gle frequency.
Although the simplified model containing the TEER
and the Ccl provides primary information about the
cell barrier, sometimes it is necessary to solve the en-
tire system. For example, it is often interesting to de-
termine the particular ion permeability of TJ or to
distinguish the electrical parameters of both mem-
branes. For such purposes, one of the five parameters
can be independently obtained and used to determine
the others. In other approaches some parameters may
be neglected when they do not contribute to the
overall impedance (e.g., the TEER is dominated by
the Rp in leaky epithelia where the Rp is much lower
than the Rt).
Measurement techniques
Ussing chamber
The Ussing chamber was an apparatus developed by the
Danish biologist Hans H. Ussing [69] in the early 1950s
to measure the active transport of sodium in frog skin
epithelium. Ussing and Zerahn demonstrated that the
rate of active transport of ions can be calculated as an
electric current across the skin if both sides are at the
same potential and have similar solutions [70]. By im-
posing these conditions, there would be no net transfer
of passive ions, and the electric current (Isc) would result
only from active transport processes. The original dia-
gram representation of the apparatus is shown in Fig. 4a
and b. It is composed of two compartments containing
the same Ringer’s solution (appropriately oxygenated
through the air inlets) and the piece of tissue under
study separating them in the middle. To measure the
potential difference and to pass the current across the
tissue, four agar-Ringer bridges link the Ringer’s solution
in the compartments with reference electrodes and
current carrying electrodes, respectively.
Fig. 3 a Equivalent electric circuit for an epithelial cellular layer. b Model with lumped apical and basolateral elements. c Lumped model including
only transepithelial electric resistance (TEER) and cell layer capacitance (Ccl). d–e Representative impedance spectra across a cell layer; data was
simulated with Rs equal to 1 kΩ, d TEER values ranging 1–1000 Ω, and e Ccl values ranging 0.1–10 μF. Rp, paracellular resistance; Rs, resistance of the
solution; Ra, apical resistance; Rb, basolateral resistance; Ca, apical capacitance; Cb, basolateral capacitance; Rt, transcellular resistance
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Transepithelial measurements that can be obtained
from Ussing chamber include Vte, TEER, and Isc. By
combining transepithelial measurements with chemically
determined net fluxes, Ussing was able to prove that the
overall Isc measured across the frog skin was produced
by the active transport of Na+ [70]. This was followed by
other works where he demonstrated that the active
transport of Na+ in reality is a forced exchange of Na+
against K+ located at the inward-facing membrane [71]
and also revealed the passive transport origin of the Cl−
ions [72], both remain unchanged today. Other authors
rapidly adopted the Ussing chamber to study other
tissues (e.g., intestinal [73], urinary bladder [74], and
kidney [75]).
To date, our knowledge about active and passive trans-
port mechanisms in epithelial tissues has vastly in-
creased thanks to the Ussing chamber; the versatility of
the apparatus is unquestionable. A primary advantage of
this system is the high accuracy of the measurement be-
cause of the uniform current distribution along the epi-
thelial sheet. Commercially available Ussing chambers
maintain the main features of the original device. A
common Ussing-like chamber can accommodate a var-
iety of tissues using interchangeable sliders even to hold
a Snapwell insert (cell culture insert supported by a de-
tachable ring).
Transwells
Transwell permeable supports are cell culture inserts to
be used with standard well plates mainly for transport
and migration studies. In general, these devices simply
comprise an insert body with a bottom filter plate. The
membrane filter serves as a cell growth substrate and
permits particles to diffuse through the filter pores.
Transwell supports have been very popular since the
1950s [76] due to their simplicity and their commercial
availability. Unlike cells on culture dishes, cells grown
on permeable supports have a basal side in which cells
can uptake and secrete molecules. This is essential to
provide an environment that better mimics the in vivo
scenario and in turn enables cell polarization. Moreover,
Transwell system facilitates the collection of samples
from both tissue sides therefore permits transport stud-
ies. Some of the human cell barriers modelled with
Transwell systems are the alveolar epithelium [77], BBB
[78, 79], and intestinal mucosa barrier [80, 81].
The electrophysiological quantification of the barrier
in Transwell cultures can be done by using a commer-
cially available handheld probe based on chopstick-like
electrodes (Fig. 4c). The probe comprises a pair of sticks
with electrodes at the ends. Each stick in turn has a
current carrying electrode (outer Ag electrode pair) and
a pick-up electrode (inner Ag/AgCl pair). With this
Fig. 4 Transepithelial electrical measurement techniques. a Original diagram representation of the Ussing chamber in 1951. Reproduced by
permissions of John Wiley and Sons [70]. b Detailed parts of the Ussing chamber. c Schematic representation of chopstick-like electrodes for use with
standard Transwell inserts. d Electric Cell Substrate Impedance Sensing system. In this technology, cells are cultured on a surface that contains a small
gold electrode (working electrode) and a large counter electrode
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tetrapolar (four electrodes) configuration, it is possible
to measure either the TEER or the Vte. The procedure to
determine the TEER requires an additional measure for
quantifying the contributions of the medium solution to
the total resistance. This is done by measuring the resist-
ance with the Transwell insert free of cells (blank read-
ing). Then, TEER can be computed as
TEER ¼ ðRtotal−RblankÞA; ð4Þ
where A is the area of the cell culture (i.e., the effective
surface area of the Transwell insert). In order to compare
TEER values, the TEER needs to be normalized by the ef-
fective area so that it is expressed in units of Ω cm2.
A disadvantage of chopstick-like systems is the proper
positioning of the sticks and the non-uniform current dis-
tribution when large membrane filters are used (> 12 mm
in diameter) [82]; in such cases, the resistance reading
should not be converted to unit area resistance. To over-
come these limitations, chopstick electrodes can be re-
placed by the so-called ‘Endohm series‘ (World Precision
Instruments, Sarasota, FL, US). This system comprises a
chamber and a cap each containing a pair of concentric
electrodes. Therefore, the applied current is more uni-
formly distributed through the whole area providing re-
producible and accurate measurements.
ECIS
Electric cell-substrate impedance sensing (ECIS) is a
technology in which cells are cultured on a surface that
contains sensing electrodes (Fig. 4d) [83]. The most
basic ECIS cultureware for monitoring barrier function
includes a small circular gold electrode of 250 μm in
diameter surrounded by a relative large electrode. Since
the working (also known as sensing) electrode is much
smaller than the counter electrode, the volume around
the working electrode contributes more to the measured
impedance than volumes far away. Cells grow on top of
this small electrode obstruct the current path that
crosses the barrier, increasing the electrical resistance.
Thus, the impedance measurement directly reflects the
tightness of the cell barrier [84]. Monitoring of the bar-
rier tightness in real time has been useful in determining
the role of specific proteins in the regulation of endothe-
lial barrier function and the barrier restoration from an
induced inflammatory stimulus [85]. By using different
electrode designs, apart from the barrier function, ECIS
technology can be used to monitor cell attachment and
spreading [86], cell migration, cell proliferation, cell in-
vasion, and cytotoxicity [87]. Electrodes can be also used
for wound healing assays apart from monitoring. For
such wounding purpose, a temporally elevated voltage is
applied to the electrode causing the death of the cells
therein. Then, the healing process can be followed in
real time [88].
The number of cells that covers an ECIS electrode of
250 μm in diameter is generally in the order of hun-
dreds; otherwise the diameter of the smallest commer-
cially available insert is around 4.2 mm in diameter
which allocates 3 orders of magnitude more cells. As a
result, measurements performed with ECIS technology
are more sensitive to cell motility and shape of small
populations of cells than methods that evaluate larger
cell cultures or tissues. Another benefit of such experi-
ments is the throughput and the reproducibility because
of the fixed electrodes. As a disadvantage, measurements
with ECIS electrodes are only representative of small
areas. In addition, transport studies are not allowed in
ECIS cultureware since there is no basal accessible com-
partment. To create this basal region, ECIS instrumenta-
tion can be combined with insert-like filter supports by
means of an adapter (e.g., 8 W TransFilter Adapter, Ap-
plied Biophysics Inc., Troy, NY, US).
Engineered biological barrier models
The early strategy to separate apical and basolateral do-
mains of cell monolayers was by means of permeable
supports. Epithelial cells on these membrane filters form
polarized monolayers with transport and permeability qual-
ities of in vivo transporting epithelia [89, 90]. Beyond these
traditional cultures, MPS are refining in vitro models by
partially emulating the cell microenvironment and the
microarchitecture of native tissues. Recent advances in bio-
materials and microfabrication technologies have allowed
scientists to attempt novel compartmentalization ap-
proaches to develop barrier models. In the following, we
discuss the applicability of the methods for the quantifica-
tion of barrier permeability in those models and describe
existing strategies for modelling biological barriers involv-
ing microengineering technologies, such as bioprinting,
which comprises those 3D printing techniques capable of
depositing biological elements (e.g., living cells and bioma-
terials); photolithography from the microelectronics indus-
try; and soft lithography, which allow processing more
physiologically relevant and low cost materials (e.g., elasto-
meric polymers). Current compartmentalized approaches
are shown in Fig. 5.
Membrane-based devices
This approach is based on a semipermeable membrane,
where the cells are cultured, that split a chamber into
two compartments. Most of these devices are made of
thermoplastic or elastomeric materials such as polydi-
methylsiloxane (PDMS), which is transparent and bio-
compatible. Permeability assays in these devices are
often easy to perform since solutions can be collected
from both apical and basolateral compartments.
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However, it presents a major challenge to achieve the
uniform current distribution required for accurate TEER
measurements within miniaturized cell culture channels
of MPS. Several researchers, including us, have proposed
particular strategies and electrode configurations to ad-
dress this issue and to allow monitoring of the barrier
state in real time [82, 91–94].
A device based on this strategy is commercially avail-
able by Emulate Inc. (Boston, MA, US) with a main field
of applications in drug development and toxicity. In a
recent study, it was successfully used to retrospectively
predict the prothrombotic side effect of a drug candidate
for treatment of autoimmune disorders that was un-
known during preclinical testing and was only revealed
in human clinical trials [95]. Similar membrane-based
systems have been widely used in the literature to model
the BBB [96, 97], the alveolar-capillary barrier [8, 98],
the hepatic sinusoid [99, 100], and renal tubular epithelia
[101, 102], among others. For example, Blundell et al.
constructed an in vitro model of placental barrier, which
protects the foetus from harmful substances and regu-
lates the transport of nutrients from the maternal to the
foetal blood [103]. For this purpose, a co-culture of hu-
man trophoblasts and foetal endothelial cells were plated
on either side of the semipermeable membrane under
flow conditions. The model reproduced the efflux trans-
port of a gestational diabetes drug (i.e., glyburide),
mostly by active transporters in trophoblast cells [104].
In vitro models that faithfully recapitulate transport
functions of placental barrier are essential to predict the
exposure of foetus to drug compounds that may com-
promise foetal development during pregnancy.
Instead of using a rigid permeable support, a flexible
membrane (e.g., PDMS) can be utilized to apply a
mechanical stretching to the cells. With this approach
Hug et al. created a ‘lung-on-a-chip‘ that models the
alveolar-capillary barrier [8]. They co-cultured micro-
vascular endothelial cells in a compartment containing
culture medium together with alveolar epithelial cells in a
superimposed compartment filled with air, obtaining a
tighter barrier (i.e., higher TEER) in this air-liquid interface
culture condition than when the tissue was submerged in
liquid. Since epithelium and endothelium are in the two
sides of the semipermeable membrane, it is not possible to
determine the TEER value of each cell monolayer. The au-
thors managed to cyclically stretch the tissue using a vac-
uum system at the sides of the compartments thus
mimicking the breathing motion of the lung. This system
was able to reproduce the effects of a pulmonary oedema
(including detrimental of the pulmonary barrier measured
through FITC-inulin transport) by administrating a cyto-
kine (interleukin-2) in the microvascular side concurrent
with the cyclic mechanical strain [105]. The same device
was also used to create a human intestinal model using
Caco-2 cells. In order to increase the absorptive surface
area, enterocytes—the specialized absorptive cells of the
intestinal epithelium—form finger-like processes that pro-
ject into the lumen (villi). Interestingly, the application of
mechanical cues—fluid flow and mechanical deformation
as in gut peristalsis—spontaneously undergoes the forma-
tion of villi and crypts, including a higher glucose uptake
rate compared to cells cultured in a Transwell insert and
differentiation of Caco-2 cells into four different cell types
[106]. In another study, it was analysed whether mechan-
ical deformations of villi affects bacterial overgrowth and
inflammation [107]. The study demonstrated that cessa-
tion of epithelial deformation triggers bacterial over-
growth, and also that immune cells and endotoxin induce
Fig. 5 Compartmentalized approaches for engineering cellular barriers including membrane-based microfluidic device, side-by-side compartments
connected through microchannels, gel-liquid interface using phaseguides, and perfusable tubules and microvascular network within an ECM
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villus injury and intestinal barrier breakdown (as indi-
cated by the decrease of TEER) because of the pro-
duction of proinflammatory cytokines by epithelial
cells (Fig. 6a).
Mechanical forces due to fluid flow in blood vessels
and epithelial tubules can be reproduced in microfluidic
devices to mimic an in vivo-like environment. For
instance, Jang et al. created a device with a microchannel
lined by kidney tubular cells from the collecting duct
[101]. Results demonstrated that cells subjected to flu-
idic flow exhibit enhanced cell polarization, cytoskeletal
reorganization, and molecular transport in comparison
with cells grown on glass substrate under static condi-
tions. In addition, the device was used to investigate the
Fig. 6 Engineered biological barrier models involving semipermeable membranes or microchannels. a A gut-on-a-chip microfluidic device with
spontaneously formation of villi resulting from mechanical cues [107]. TEER profile shows intestinal barrier injury in the presence of pathogenic bacteria
(EIEP) or immune cells plus either non-pathogenic bacteria (GFP-EC) or lipopolysaccharide (LPS) endotoxin. b A human kidney proximal tubule-on-a-chip.
Immunofluorescence images and bar plots shows increased cell height and increased expression of the tight junction protein ZO-1, aquaporin 1 (AQP1;
green), Na/K-ATPase (magenta), and primary cilia in epithelial cells under flow conditions. Adapted from [109] with permission from The Royal Society of
Chemistry. c Microfluidic platform for the development of human skin equivalents. Histological and immunofluorescence images demonstrate an
improved epidermal morphogenesis and dermoepidermal junction when the tissue is maintained in a dynamic air-liquid interface. Adapted from [110]
with permission from Elsevier. d Neonatal BBB model consisted of side-by-side chambers connected through microchannels [114]. Immunofluorescence
image shows direct contact communication between endothelial cells (ZO-1; green) and astrocytes (astrocytic marker GFAP; red). e Microfluidic model of
the BRB where cells are arranged in parallel compartments and interconnected through a grid of microgrooves [10] – Adapted by permission of The Royal
Society of Chemistry. TEER measurement during a calcium switch procedure is performed with two electrodes in the basal side instead of in the apical
and basal sides. f Scalable liver-on-a-chip microdevice for long-term maintenance of hepatocyte function in vitro, in which microchannels artificially mimic
the fenestrated endothelial cells of the liver [115] (Copyright IOP Publishing. Reproduced with permission. All rights reserved)
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role of fluid shear stress in translocation of aquaporin-2
(a vasopressin-regulated apical water channel) [108]. A
model of kidney proximal tubule was also developed in
that microfluidic device for nephrotoxicity assessment
[109], where proximal epithelial cells were subjected to
flow and exposed to the nephrotoxin cisplatin (Fig. 6b).
The tubule-on-a-chip better predicted nephrotoxicity in
the human kidney compared to conventional cultures
and even reproduced nephrotoxicity recovery after injec-
tion of cimetidine which has shown to suppress its toxic
effects in canines. A dynamic environment was also used
to promote the development of human skin equivalents.
Sriram et al. cultured keratinocytes on a fibrin-based
dermal matrix containing fibroblasts (i.e., a dermal
equivalent) previously integrated into a microfluidic plat-
form for continuous perfusion and ventilation of the tis-
sue (Fig. 6c) [110]. By maintaining the tissue in the
dynamic air-liquid interface, the skin model exhibited
improved epidermal differentiation, barrier function (i.e.,
lower permeability), and a more robust dermoepidermal
junction compared to skin equivalents cultured in stand-
ard tissue culture inserts. Importantly, the dermoepider-
mal junction had a basement membrane with increased
expression of proteins from the collagen and laminin
families, which are essential for cells to attach to the
ECM and thus prevent epidermal detachment.
Membrane-based microfluidic devices have also been
designed to allocate several epithelial and endothelial cell
monolayers. Wufuer et al. fabricated a device composed
of three layers of PDMS together with two intermediate
porous membranes. They developed a ‘skin-on-a-chip‘-
model that mimics the cell layer physiology of the hu-
man skin consisting of epidermal, dermal, and
endothelial layers [111]. The authors optimized a model
of skin inflammation and oedema by applying TNF-α, as
revealed from the delocalization of the TJ protein ZO-1,
increased permeability to FITC-dextran (4 kDa), and an
elevated pro-inflammatory cytokine profile. In addition,
they also demonstrated the ability of the device for drug
testing by reversing the pathological scenario through
the administration of dexamethasone to treat the in-
duced inflammation. A cell sheet stratification technique
has also been used to construct several layered tissues.
This technique is based on harvesting and stratifying
contiguous cell sheets on a culture insert by means of a
custom-made manipulator. Since the tissue lies on an in-
sert membrane, it is possible to conduct TEER measure-
ment and permeability assays as in Transwell systems.
Using this methodology, Kim et al. fabricated a stacking
of three cell layers mimicking the hepatic plate (i.e., he-
patocytes forming layers of 1–2 cell thick) in the liver
surrounded by two monolayers of sinusoidal endothelial
cells [112]. Similar 3D cell stacking can be currently
constructed by using bioprinting techniques. Horvath et
al. [98] created alveolar-capillary barriers in vitro by a se-
quence of prints, including an endothelial cell layer, an
ECM layer, and an epithelial cell layer. The methodology
demonstrated high reproducibility and capability to
achieve a very thin tissue barrier, comparable to the
physiological thickness of the basement membrane
found in native tissues (1.6 μm) which is critical for an
adequate oxygen uptake. Artificial materials (e.g., plastic
semipermeable membranes) used as a cell support can
partially restrict the diffusion of solutes or a direct con-
tact communication between heterotypic cells.
Microchannels
Microchannels that physically link two side-by-side cham-
bers have also been used as a compartmentalization strat-
egy [113]. In this approach, cells are cultured in one of the
chambers to form a cell monolayer that completely covers
the inner surfaces. With a microchannel size of a few mi-
crons, epithelial or endothelial cells lining the chamber
would be unable to pass through the microchannels
whereas biomolecules could diffuse through them. In
addition, supporting cells in the adjacent compartment
could extend cytoplasmic processes to enable a direct con-
tact between heterotypic cells (e.g., astrocytic end-feet ex-
tended along the microchannels). The planar disposition
of the compartments enables real-time fluorescence im-
aging of the whole cell culture to calculate the Papp of test
compounds. In this kind of systems,V/S substitutes r/2 in
Eq. 1 where V is the volume of the vascular compartment
and S is the permeable surface (i.e., the area of the micro-
channels). Otherwise, TEER measurements can be con-
ducted by integrating electrodes in both compartments or
by threading wire electrodes through the outlets and in-
lets. However, special care has to be taken in expressing
the TEER in units of Ω cm2 since the current distribution
may be unobvious in these systems with microchannels.
A microfluidic chip based on microchannels is com-
mercially available from SynVivo Inc. (Huntsville, AL,
US). The device consists of a PDMS slab containing the
fluidic microstructures bonded to a glass slide, which fa-
cilitates real-time imaging. In a work by Deosarkar et al.,
the SynVivo chip was used to develop a model of BBB
by culturing rat brain capillary endothelial cells with ei-
ther astrocytes or an astrocyte conditioned medium (Fig.
6d) [114]. Both cell cultures exhibited improved barrier
formation that was supported by permeability to tracers
and electrical resistant measurements, in contrast to just
endothelial cultures. Interestingly, Papp of 40 kDa dex-
tran closely mirrored the permeability of rat brain capil-
laries in vivo.
In our group, we developed a compartmentalized micro-
fluidic device to allow the real-time monitoring of several
cell monolayers and their heterotypic cell-cell interaction
(Fig. 6e) [10]. The device included crisscross microgrooves
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on a glass substrate to address the challenge of intercon-
necting several tissue-tissue interfaces. In addition, elec-
trodes were integrated in the substrate for the
electrophysiological monitoring of several barrier tissues.
As a proof-of-concept, we used it to recapitulate the cell
structure of the retina mimicking both inner and outer
blood-retinal barriers.
Engineered microchannels have also been used as a
microfluidic endothelial-like barrier. Several authors
have artificially reproduced the very leaky endothelium
of the liver sinusoid by the microchannels themselves
(Fig. 6f ). Despite the lack of cell functionalities (i.e., no
endothelial cells), a non-biological barrier can simulate
some mass transport properties of blood vessels to
maintain for long term the phenotype and functions of
primary hepatocytes in cell cultures [115, 116].
Gel-liquid interface
Gel-liquid interfaces can physically support the cells
while enabling a direct contact interaction between tis-
sues. These interfaces can be microfabricated by means
of phaseguides structures that act as capillary pressure
barriers [117]. The function of these structures is to se-
lectively pattern a gel in a central lane by meniscus pin-
ning, so cells could proliferate in the interface between
the gel (e.g., an ECM hydrogel) and the liquid (e.g., cul-
ture medium) in adjacent lanes. This technology is com-
mercially available by Mimetas (Leiden, NL) in a
high-throughput microfluidic platform called Organ-
Plate. Trietsch et al. used it to develop up to 40 replicas
in a single platform of a model of intestinal tract epithe-
lium (Fig. 7a) [118]. They created perfusable polarized
epithelial tubes using Caco-2 cells and assessed its barrier
integrity during drug-induced cell death. For that purpose,
fluorescent tracers are added in the luminal side and
time-lapse fluorescence images are automatically taken in
the ECM hydrogel. Then, the Papp of a tracer may be cal-
culated as in microchannels approach using Eq. 1; or also
effective concentrations and exposure times of drug com-
pounds may be determined for pharmacological studies.
Unlike cells cultured on 2D monolayers, it is difficult to
carry out transepithelial electrical measurements on perfu-
sable tubules where cells cover all the walls of a channel.
Therefore, in vitro models of tubules or vessels often only
combine immunocytochemistry and permeability assays
to quantify the transepithelial transport.
A hydrogel channel can also be defined using equally
spaced post structures. The surface tension caused by
these structures will prevent the hydrogel from entering
in between the posts [119]. Wang et al. developed a
microfluidic device able to trap primary glomerular
microtissues into ECM semilunar substrates and succeed
in forming glomerular filtration barriers including endo-
thelial cells, basement membrane, and podocytes that
entirely covered the ECM surface (Fig. 7b) [120]. In par-
ticular, the microdevice was found suitable for modelling
diabetic nephropathy—a chronic loss of kidney function
in people with diabetes mellitus—since microtissues
under high glucose conditions exhibited, in a
dose-dependent manner, barrier dysfunction, increased
albumin permeability, and excessive reactive oxygen spe-
cies production, which are closely associated in the pro-
gression of diabetic nephropathy. To permit co-cultures
and thus emulate heterotypic cell-cell interactions, cells
can be added to the gel preparation before filling the
channels. For instance, a neurovascular unit consisting
of human microvascular endothelial cells mimicking
cerebral blood vessels, primary rat neurons, and astro-
cytes was constructed with multiple side-by-side ECM
and fluidic channels (Fig. 7c) [121]. Moreover, gel-liquid
approach has enabled cell migration studies in response
to specific cytokines such as tumour cell intravasation
(i.e., migration towards blood vessels) under TNFα expos-
ure [122] or tumour cell extravasation (i.e., migration from
blood vessels) under chemokine CXCL5 [123]. In another
work, cell migration caused by epithelial-mesenchymal
transition (EMT) (a biological process by which polarized
epithelial cell acquires a mesenchymal phenotype) was ini-
tiated in proximal tubular epithelial cells covering a base-
ment membrane extract in a microfluidic device [124]. In
response to serum proteins, cells become myofibroblasts
and migrated within the gel. EMT has been proposed to
be an early stage of fibrotic disorders, such as kidney inter-
stitial fibrosis which is characterized by an excessive accu-
mulation of ECM in the interstitial space. Since
observation of EMT process is extremely difficult in vivo,
MPS have become relevant in vitro tools to reproduce and
follow in real-time this process.
Three-dimensional characteristic features of native tis-
sues have been reproduced in in vitro by structuring gel
surfaces. For example, hydrogel scaffolds with an array
of finger-like elements that mimic in vivo villi were de-
veloped to support intestinal epithelial cells [125]. For
this purpose, a microfabricated alginate mould was used
to create the 3D scaffold by pouring a pre-gel solution
that was subsequently polymerized and detached from
the mould after dissolving the alginate [126]. In that
study, the expression of MUC17 (which is a transmem-
brane mucin responsible for the protective layer of
mucus against pathogens) was higher in presence of the
3D organization than in 2D models and, interestingly, its
knockdown compromised the intestinal barrier function.
On the other hand, TEER measurements and tracer as-
says have evidenced a leakier barrier for intestinal epi-
thelial cells cultured on 3D villi-like structures
compared to Transwell inserts [125, 127], which is
accounted for a decreased expression of tight junctions
[128] and an increased cell culture area in the 3D model.
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Tubules and vessels embedded within an ECM
The latter microengineered approach consists in embed-
ded tubules or microvascular networks into an ECM.
Such epithelia and endothelia can be constructed either
by creating fluidic microchannels that are later lined
with cells or by forming channels of hydrogel laden
with cells that results in branching microvessels. The
primary advances of these approaches are the rele-
vant 3D architecture and the capacity to perfuse the
microvessels or tubules. In this approach, there are
no straightforward solutions to determine the elec-
trophysiological properties of 3D architectures (e.g.,
microvessels with circular cross-sectional geometries)
contained within microchannels; the access to
Fig. 7 Engineered biological barrier models involving gel-liquid interface or tubules and vessels embedded within an ECM. a Intestinal epithelium tubule
in a microfluidic channel created with a gel interface [118]. As revealed by immunofluorescence, cells form a confluent layer lining the whole channel
which results in a perfusable lumen. b Glomerulus-on-a-chip microdevice. Glomerular microtissues are adhered to a gel surface and self-assembled into a
continuous barrier of endothelial cells (CD31; red) and podocytes (synaptopodin; green) under flow perfusion. Adapted from [120] with permission from
The Royal Society of Chemistry. c Three-dimensional neurovascular microfluidic model that enables heterotypic cell-cell interactions; it comprises human
microvascular endothelial cells mimicking cerebral blood vessels, primary rat neurons, and astrocytes. Adapted from [121] with permission from The Royal
Society of Chemistry. d Bioprinting method for creating 3D human renal proximal tubules in vitro that are fully embedded within an ECM, including
printing of a sacrificial ink, casting of an ECM, evacuation of the ink, and cell seeding [9]. e Three-dimensional bioprinting of thick vascularized tissue
consisted of a perfusable vascular network using hUVECs surrounded by hMSCs and fibroblasts [129]. Immunofluorescence image shows osteogenic
differentiation (Osteocalcin; violet) of hMSCs in situ after administration of specific growth factors via the vascular network. f A perfusable microvascular
network grown in a hydrogel channel. The obtained network exhibits relevant morphological characteristics of in vivo blood vessels. Adapted from [134]
with permission from The Royal Society of Chemistry
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microvessels embedded in microchannels is limited
unlike isolated tubules that can be cannulated or in
situ measurements where vessels can be micropunc-
tured. For such purpose, permeability assays with
fluorescent markers offer an accurate way to check
the integrity of microvessel networks within
microchannels.
Homan et al. reported a bioprinting methodology to
create 3D renal proximal tubules on demand (Fig. 7d)
[9]. They constructed a convoluted tubule by printing a
sacrificial ink that was embedded within an ECM and
subsequently removed. Finally, the convoluted tubular
channel (~350 μm in diameter) was filled with cells, per-
fused with culture medium, and allowed to form a
monolayer lining the channel. The 3D in vitro tubule be-
sides recreating a cyclosporine-dependent nephrotoxicity
exhibited enhanced epithelial phenotype (e.g., cell height,
microvilli development, and albumin uptake) than con-
ventional 2D cell cultures.
Similar bioprinting methodology was employed by
Kolesky et al. to develop a perfusable vascular net-
work contained by an ECM (Fig. 7e) [129]. They
managed to obtain a thick (> 1 cm) 3D fluidic net-
work interconnecting various lattice patterns of sacri-
ficial ink. After liquefying and evacuating the ink,
channels of the network were lined with human um-
bilical vein endothelial cells (HUVECs) to form a
vascularization system. In addition, hMSCs and fibro-
blasts were incorporated in the surrounding ECM as
a parenchyma and connective tissue, respectively. The
long-term administration of specific growth factors
via the vascular network promoted the osteogenic dif-
ferentiation of hMSCs in situ; thus being able to re-
capitulate heterogeneous complex tissue architectures
and enabling its maturation.
Another methodology is the so-called ‘viscous finger
patterning’ that can be used to create lumens with
circular cross-sectional geometries. For this purpose, a
droplet of culture medium is placed on the inlet of a
microchannel previously loaded with pre-polymerized
hydrogel solution. As a result, the culture medium
flows through the centre of the microchannel dis-
placing the hydrogel [130]. After polymerization of
the hydrogel, there remains a patterned lumen that
can be lined with endothelial cells to mimic a blood
vessel [131]. Furthermore, endothelial cells can be
combined with supporting cells by seeding them first
on the luminal wall or by incorporating them in the
hydrogel solution. For example, a co-culture of pri-
mary human brain microvascular endothelial cells,
pericytes, and astrocytes was developed with this
technique to mimic the BBB [132]. Under inflamma-
tory stimulation with TNF-α and compared to Trans-
well cultures, the vascular system showed a profile of
secreted cytokines that closely mimicked those ob-
served in the living brain.
Relatively complex vascular structures can also be
engineered using soft lithography techniques instead of
3D printing. For example, a scaffold made of biodegrad-
able elastomer was constructed by stacking several
microfluidic layers [133]. In that work, the authors built
a scalable vascular system containing fluidic branches
that were covered with hUVEC. Combining this engi-
neered vessel network with parenchymal cells such as
rat hepatocytes or cardiomyocytes, they constructed
functional vascularized liver and cardiac tissues, respect-
ively. In particular, the latter was implanted in rat fem-
oral vessels via direct anastomosis, which supports its
applicability for regenerative medicine.
Unlike systems with defined vasculature, the develop-
ment of microvessel networks within an ECM can
closely mirror their in vivo morphology. Kim et al. dem-
onstrated the spontaneous formation of interconnected
networks of microvessels in a microfluidic device using
hUVEC (Fig. 7f ) [134]. The device consisted of five
side-by-side channels separated by posts, in which the
central channel was filled with hydrogel. Either the
hydrogel laden with the endothelial cells or the cells
coating one of the sides of the hydrogel resulted in the
proliferation of a long-term stable perfusable micro-
vascular network; the sine qua non of this formation
were growth factors secreted by supporting cells (i.e.,
human normal lung fibroblasts) that were co-cultured in
a lateral channel. In addition, endothelial cells exposed
to flow-induced shear stress exhibited some physio-
logical responses (i.e., cytoskeleton reorganization and
nitric oxide synthesis) of in vivo vessels. A very similar
device was used to model choroidal neovascularization
in age-related macular degeneration, wherein new blood
vessels from the retinal choroid abnormally grew to-
wards the retinal pigmented epithelium compromising
the outer BRB [135]. They combined a perfusable blood
vessel network embedded in an ECM with a cell mono-
layer of retinal epithelial cells attached to the ECM,
where both tissues were separated by a gap channel. The
administration of VEGF at high concentrations in the
apical side of the retinal epithelium induced the prolifer-
ation of new vessels that penetrated the RPE monolayer.
Otherwise, bevacizumab (a current drug for the
age-related macular degeneration treatment) was found
to inhibit choroidal neovascularization caused by VEGF
and therefore vessel invasion. In a different approach, it
was developed a platform based on a standard 96-well
plate with six microfluidic units for similar purposes, in-
cluding a hydrogel chamber for vasculogenesis and two
microfluidic channels for continuous nutrients supply
[136]. The device was found suitable for generating per-
fusable microvessels networks and especially for
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screening of drugs, as they tested the efficacy of
well-known anti-angiogenic and anti-cancer drugs in a
tumoral environment by co-culturing cancer cells.
Conclusions and future perspectives
Epithelial and endothelial barriers are crucial to maintain
organ homeostasis and their deregulation play an im-
portant role in the pathogenesis and progression of
many prevalent human diseases. Most in vitro models of
biological barriers, typically based on Petri dishes or
Transwell inserts, are restricted to one or two different
cell types and are inadequate to apply controlled phys-
ical or biochemical stimuli that emulate the in vivo
microenvironment. Taking advantage of the available
microfabrication techniques and biomaterials as well as
the synergies between biologists and engineers, it has
been possible to refine conventional in vitro models to-
wards more sophisticated MPS able to better predict hu-
man response. Current MPS are heterotypic cell cultures
with physiologically relevant organizations, where cells,
for example, can be embedded in an ECM with a par-
ticular stiffness, seeded on a surface with certain topog-
raphy, subjected to mechanical forces such as
flow-induced shear stress and cyclic stretching, or ex-
posed to concentration gradients of cytokines and
growth factors.
In addition to facilitating real-time imaging, an advan-
tage of many MPS modelling tissue barriers is the inte-
gration of electrodes for continuous monitoring of
transepithelial electrical parameters. Nevertheless,
obtaining accurate transepithelial measurements with
these systems is not easy. To date, electrophysiology of
the paracellular pathway where TJ reside has been ad-
dressed by measuring large cell culture areas with count-
less cells. It is likely that new tools emerge in the future
able to record the ionic conductances of individual chan-
nels in tight junctions. This unprecedented spatial reso-
lution measurement would give new insights into the
underlying mechanisms of barrier regulation in molecu-
lar terms.
In vitro barrier models are suitable for studying the
ability of pharmaceutical compounds to cross biological
barriers, since these are the major impediment for
agents to reach targeted tissues during drug delivery. In
addition, barrier models are useful to quantify the trans-
epithelial transport of drugs and thus provide informa-
tion about times and doses at which organs are exposed
to the drug for toxicity testing. Engineered MPS using
human cells (e.g., primary cells or stem cells) have a high
potential in many applications including drug screening,
disease modelling, and regenerative medicine. In particu-
lar, the combination of these systems and stem cell tech-
nologies is a promising tool for the development of the
so-called ‘precision medicine’, in which patient-derived
cells are used for a personalized treatment.
Despite the progress made to develop representative
MPS, many challenges remain to be addressed. For ex-
ample, when dealing with heterotypic cell cultures, every
tissue thrives in a specific cell culture medium that can
differ from the others. Moreover, the heterogeneity of
cells is detrimental for controlling the cell microenviron-
ment of each cell type, which is a major advantage of
MPS. On the other hand, microfabrication using soft
lithography is appropriated to reproduce the cell
organization of native tissues since it enables features in
the sub-micron range; however, it requires the stacking
of several patterned layers to build complex 3D struc-
tures, which results in a cumbersome fabrication
process. Meanwhile, bioprinting technology is still in its
infancy but is expected to grow rapidly if some issues re-
lated to print speed, bioinks viscosities, and printer cost
can be improved. Another challenge is to find biomate-
rials compatible with the microengineering techniques
and also inert to the bind of drugs and compounds. Fi-
nally, it is desirable to develop user-friendly MPS that
could be handled for non-skilled personnel and adapted
to common equipment in cell culture laboratories.
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